[IS AN IMPROVEMENT IN THE DIMETHYLAMINOETHANOL EFFECT BY THE USE OF ADJUVANTS DEMONSTRABLE IN THE CLINICAL EXPERIMENT?].
D000276:Adjuvants, Immunologic; D000277:Adjuvants, Pharmaceutic; D000605:Amino Alcohols; D001342:Autonomic Nervous System Diseases; D002318:Cardiovascular Diseases; D003642:Deanol; D006801:Humans
D000276:Adjuvants, Immunologic; D000277:Adjuvants, Pharmaceutic; D000605:Amino Alcohols; D003642:Deanol
AMINO ALCOHOLS; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASES
IST IM KLINISCHEN VERSUCH EINE VERBESSERUNG DES DIMETHYLAMINOAETHANOL-EFFEKTES DURCH ZUSATZSUBSTANZEN NACHWEISBAR?